Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Apoptosis stim
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
sotigalimab
(PYX-107) / Pyxis Oncology
Zinapar
(darinaparsin) / Solasia, Meiji Seika, Nippon Kayaku
neihulizumab
(ALTB-168) / AltruBio
imifoplatin
(PT-112) / Promontory Therap
mapatumumab
(HGS-ETR1) / GSK
BP-C1
/ Meabco
BXQ-350
/ Bexion
MT-3724
/ Molecular Templates
Nerofe
(84AA-API 14AA) / Immune System Key
foslinanib immediate release
(CVM-1118) / TaiRx
MRX2843
/ Meryx
PAC-1
/ Vanquish Oncology
Reqorsa
(quaratusugene ozeplasmid) / Genprex
aminoflavone Prodrug
(AFP-464) / Kirax
lisavanbulin
(BAL101553) / Basilea
ABI-2280
/ Antiva Biosci
PankoMab-GEX
(gatipotuzumab) / Glycotope
SVV-001
/ Seneca Therap
TLX101
/ Telix
disitertide
(P144) / Digna Biotech
perillyl alcohol
(NEO100) / NeOnc Technologies
AB8939
/ AB Science
ABT-737
/ AbbVie
DTRM-555
/ Zhejiang DTRM Biopharma
ImmuniStim
(expanded allogeneic γδ T-lymphocytes) / TC Biopharm
LipoCurc
(liposomal curcumin) / Signpath Pharma
A6
/ Angstrom
ImmuniCell
(autologous γδ T lymphocytes) / TC Biopharm
Kanglaite gelcap
(KLTc) / Zhejiang Kanglaite Pharma
PF-114
/ AstraZeneca
PVT-1
/ PlusVitech
alpha lactalbumin oleic acid
(Alpha1H) / Linnane Pharma
para-toluenesulfonamide
(PTS100) / Gongwin Biopharm
